Navigation Links
FDA Gives 510k Clearance to EyeKor’s EXCELSIOR™ Cloud-based Image Management Software for Ophthalmic Clinical Trials
Date:5/3/2013

DAVIS, CA and MADISON, WI (PRWEB) May 03, 2013

EyeKor, LLC, a new service provider dedicated to the support of ocular clinical trials, announces FDA 510k clearance of its EXCELSIOR™ image management software as a class 2 medical device, with indications for use specifically for managing ophthalmic clinical trial data. A first-of-its kind web application, EXCELSIOR™ employs a unique cloud-based architecture to enhance efficiency and accuracy in the collection and interpretation of data from ophthalmic clinical trials. EXCELSIOR™ provides a framework in which images from multiple imaging modalities can be reviewed and analyzed concurrently.

According to EyeKor CEO Christopher J. Murphy, DVM, PhD, “EXCELSIOR™ is unique: No other software leverages data from such a wide variety of ophthalmic instruments while providing such a transparent workflow and ease of access.”

Murphy continues: “EyeKor’s unique relationships with nationally recognized reading centers position it to support EXCELSIOR™ by harnessing the expertise of multiple reading centers with a broad range of functionalities.” These include fundus imaging, corneal imaging, visual field assessment, and electrophysiology—all of which can be viewed and assessed from within the unified EXCELSIOR™ platform.

EXCELSIOR™ provides investigators, clinical trial sponsors, and data managers secure, real-time access to their data and lets them follow its progress through each workflow stage—collection, quality analysis, grading, and interpretation—through a browser interface. The platform is supported by Reading Center trained staff and technicians, who provide certification, clinical site support, and quality analysis of the images—with all analysis and grading harmonized by the EXCELSIOR™ custom viewer that features image-enhancement tools specifically configured for ease of use.

From acquisition to final analysis, EXCELSIOR™ is uniquely designed to meet the demands of ophthalmic clinical trials. EXCELSIOR™ leverages its web-based architecture, an intuitive workflow with a custom toolset, and a network of highly skilled clinical experts to provide faster, more accurate results across multiple test modalities in an accessible and transparent way. Murphy states: “This is the most streamlined and comprehensive software available to help ensure the successful analysis of ophthalmic clinical trial data.”

About EyeKor, LLC.
EyeKor, LLC., provides access to a coordinated network of established reading centers and clinical trial experts that offers a complete spectrum of integrated ophthalmic clinical trial services. The EXCELSIOR™ software platform is used to harmonize processes between diverse reading centers. EyeKor experts are unified through common standard operating procedures (SOPs), quality control and assurance, regulatory compliance, and computing infrastructure. The company’s expertise encompasses a diverse array of ophthalmic testing methods that include fundus photograph and angiography, optical coherence tomography, fundus autofluorescence imaging, automated visual field testing, specular microscopy imaging and electrophysiological testing.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10686249.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Gives Green Light to Publish Controversial Bird Flu Research
2. Image share project gives patients and physicians anytime, anywhere access to medical images
3. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
4. UMD team gives drug dropouts a second chance
5. FDA Panel Gives Blessing to New Weight-Loss Drug
6. Amazon Tribe Gives Clues to Heart-Healthy Lifestyles
7. Killer stainless steel: New process gives icon of cleanliness antibacterial coating
8. Aurora Dentist Gives Patients Big Savings With Teeth in a Day Implants
9. OC Firm Gives Back to Young Athletes
10. Study Gives First Evidence That Adult Human Lungs Can Regrow
11. FDA Gives Nod to New Breast Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology: